Left Ventricular hypertrophy is outlined as an increase in the mass of the left ventricle, which may also be secondary to an expand in wall thickness, and broaden in cavity measurement. Left ventricular hypertrophy more often than not develops steadily. Whilst ventricular hypertrophy happens naturally as a response to aerobic undertaking and strength coaching, it is most commonly known as a pathological response to cardiovascular disorder, or high blood stress.
Treatment for LVH focuses on the underlying the cause of the condition. Depending on the cause, Treatment may include medication or surgery. Doctor suggests the treatment for LVH such as regular exercise a low-sodium, low-fat diet and no smoking. They used to control the blood pressure by using some types of drugs like enalapril (Vasotec), lisinopril (Prinivil, Zestril) and captopril (Capoten), atenolol (Tenormin), carvedilol (Coreg), metoprolol (Toprol XL) and bisoprolol (Zebeta) and etc.
There were 33 female and 67 male patients. All the patients in the study belonged to the age group of 41-80 years. Most of the patients i.e., 41 patients belonged to the age group of 61-70 years. Out of the total 100 patients, 69 patients had LVH. In the severe CKD group, 39 patients (88.63%) had LVH. In the moderate CKD group, 18 patients (51.42%) had LVH. In the mild CKD group, 12 patients (57.14%) had LVH. Serum creatinine was significantly higher in the severe CKD group when compared to the moderate and mild CKD groups. There was no statistically significant difference seen in the age, blood pressure and serum calcium between the three categories of CKD patients